We are live on ! Find out more
BS

Boenning & Scattergood Portfolio holdings

AUM $622M
1-Year Est. Return 8.79%
This Fund
S&P 500
This Quarter Est. Return
+11.62%
1 Year Est. Return
-8.79%
3 Year Est. Return
+34.52%
5 Year Est. Return
10 Year Est. Return
AUM
$334M
AUM Growth
+$47.3M
Cap. Flow
+$13.4M
Cap. Flow %
4.02%
Top 10 Hldgs %
23.72%
Holding
289
New
27
Increased
129
Reduced
87
Closed
9

Top Buys

Rank Stock Value
1
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$2.41M
2
CVS icon
CVS Health
CVS
+$1.67M
3
WFC icon
Wells Fargo
WFC
+$1.58M
4
TGT icon
Target
TGT
+$1.34M
5
ABBV icon
AbbVie
ABBV
+$1.3M

Sector Composition

Rank Sector Weight
1 Healthcare 16.34%
2 Technology 13%
3 Industrials 10.2%
4 Financials 9.85%
5 Energy 8.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MLNT
276
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
$124K 0.04%
34,900
FMO
277
DELISTED
Fiduciary/Claymore Energy Infrastructure Fund
FMO
$116K 0.03%
2,200
RAD
278
DELISTED
Rite Aid Corporation
RAD
$111K 0.03%
8,775
+4,865
+124% +$75.1K
PSLV icon
279
Sprott Physical Silver Trust
PSLV
$12B
$90K 0.03%
16,240
MGF
280
Aberdeen Government Markets Income Fund
MGF
$91.6M
$59K 0.02%
13,049
CLDX icon
281
Celldex Therapeutics
CLDX
$2.99B
-4,997
Closed -$15K
IBB icon
282
iShares Biotechnology ETF
IBB
$9.34B
-11,674
Closed -$1.13M
IXP icon
283
iShares Global Comm Services ETF
IXP
$529M
-7,000
Closed -$351K
KHC icon
284
Kraft Heinz
KHC
$30.7B
-5,440
Closed -$234K
MINT icon
285
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$16.9B
-2,157
Closed -$218K
MXI icon
286
iShares Global Materials ETF
MXI
$338M
-3,712
Closed -$213K
TLT icon
287
iShares 20+ Year Treasury Bond ETF
TLT
$42.1B
-5,783
Closed -$703K
XME icon
288
State Street SPDR S&P Metals & Mining ETF
XME
$3.87B
-7,954
Closed -$208K
EVP
289
DELISTED
Eaton Vance Pennsylvania Municipal Income Trust
EVP
-26,600
Closed -$296K

Similar funds

Boenning & Scattergood's Q1 2019 Portfolio in Review

As of Q1 2019, Boenning & Scattergood held 289 positions worth $334M, up 17% from $287M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Boenning & Scattergood deployed $13.4M of net new capital in Q1 2019, opening 27 new positions and adding to 129 existing holdings. Its largest new stake was Target: 18,390 shares worth $1.48M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 17% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Universal Health Realty Income Trust, an estimated $5.13M trimmed.

  • Boenning & Scattergood's largest Q1 2019 buy was Target: 18,390 shares worth $1.48M.
  • Boenning & Scattergood added most to Vanguard FTSE Developed Markets ETF in Q1 2019, an estimated $2.41M increase.
  • Boenning & Scattergood's biggest Q1 2019 reduction was Universal Health Realty Income Trust, cutting an estimated $5.13M.
  • Boenning & Scattergood fully exited iShares Biotechnology ETF in Q1 2019, selling an estimated $1.13M.
  • Boenning & Scattergood's ten largest holdings make up 24% of its $334M portfolio in Q1 2019.
  • Boenning & Scattergood opened 27 new positions and closed 9 in Q1 2019.
  • Boenning & Scattergood's portfolio value rose 17% quarter-over-quarter to $334M.

Based on Boenning & Scattergood's 13F filing for Q1 2019, filed 22 Apr 2019.